Envisagenics · 2 days ago
Marketing Manager
Wonder how qualified you are to the job?
Maximize your interview chances
Artificial Intelligence (AI)Bioinformatics
Insider Connection @Envisagenics
Responsibilities
Develop and implement comprehensive marketing strategies to promote Envisagenics’ collaborations, products, and accomplishments with the help of the operations team
Collaborate with R&D and science teams to understand offerings to deliver compelling marketing campaigns and messaging
Strategize, draft, and edit written and graphical content such as presentations, brochures, videos, website copy, blog posts, and social media campaigns
Compose and maintain scientific company presentations that promote corporate identity
Spend time in the market gathering qualitative feedback and analyzing trends from clients and competitors to develop a deeper understanding of industry-wide opportunities and challenges
Measure and report on the effectiveness of marketing campaigns using analytics tools
Attend and represent Envisagenics at industry events
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
At least three years of experience in biotech or life science marketing. Management experience a plus.
MA degree or higher in a related scientific discipline—oncology or neurology experience preferred
Strong understanding of marketing effectiveness analysis tools
Strong understanding of Monday.com, Mailchimp, Canva, and Microsoft Suite, especially Powerpoint.
Familiarity with computational modeling or drug discovery informatics is a plus
Ability to travel to represent the company at events, conferences and panels.
Benefits
Healthcare (with dental, vision, fertility)
401k matching program
Pre-tax commuter benefits
Flexible work schedule
Generous parental leave program
Over a month of paid vacation time
Company
Envisagenics
Envisagenics reduce the complexity of biomedical data to accelerate the development of innovative therapeutic solutions.
Funding
Current Stage
Early StageTotal Funding
$27.06MKey Investors
National Cancer InstituteRed Cell PartnersNational Institutes of Health
2023-05-11Series A· Undisclosed
2022-08-02Grant· $2M
2021-09-29Series A· $19.18M
Leadership Team
Recent News
2024-06-05
2024-06-05
Company data provided by crunchbase